Neuropeptides as signal molecules in common with leukocytes and the hypothalamic-pituitary-adrenal axis

被引:27
作者
Smith, Eric M. [1 ]
机构
[1] Univ Texas Galveston, Med Branch, Dept Psychiat & Behav Sci, Galveston, TX 77555 USA
关键词
Psychoneuroimmunology; neuroinummology; HPA axis; ACTH; CRF; endorphin; NF-kappa B; neuroendocrine; leukocytes;
D O I
10.1016/j.bbi.2007.08.005
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There exists a bidirectional regulatory circuit between the nervous and immune systems. This regulation has been shown to be mediated in part through neuroendocrine hormones and cytokines. Both systems have receptors for both types of signal molecules. The nervous system has receptors for cytokines and it also synthesizes cytokines. The immune system synthesizes and responds to cytokines. So, it is not too farfetched to believe that neuroendocrine peptide hormones could bind to leukocytes and modulate immune functions. However, it is not widely known that the immune system also synthesizes functional, neuropeptide hormones. This will be discussed in this paper citing a plethora of evidence. The aim of this paper is to summarize this evidence by using three neuropeptides that are synthesized by leukocytes and modulate immune functions as examples; corticotropin (ACTH), endorphin (END), and corticotropin releasing factor (CRF). The production and action of these three neuropeptides in the immune system will be explained. Finally, the potential physiological role of leukocyte-derived ACTH, END, and CRF in inflammation as a localized hypothalamic-pituitary-like axis is discussed. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:3 / 14
页数:12
相关论文
共 125 条
[1]   CORTICOTROPIN-RELEASING FACTOR MESSENGER-RNA IN RAT THYMUS AND SPLEEN [J].
AIRD, F ;
CLEVENGER, CV ;
PRYSTOWSKY, MB ;
REDEI, E .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :7104-7108
[2]  
ALVAREZMON M, 1985, J IMMUNOL, V135, P3823
[3]  
Audhya T, 1988, Trans Assoc Am Physicians, V101, P62
[4]   IMMUNOSUPPRESSION BY GLUCOCORTICOIDS - INHIBITION OF NF-KAPPA-B ACTIVITY THROUGH INDUCTION OF I-KAPPA-B SYNTHESIS [J].
AUPHAN, N ;
DIDONATO, JA ;
ROSETTE, C ;
HELMBERG, A ;
KARIN, M .
SCIENCE, 1995, 270 (5234) :286-290
[5]  
BAEUERLE PA, 1994, ANNU REV IMMUNOL, V12, P141, DOI 10.1146/annurev.immunol.12.1.141
[6]   Peripheral corticotropin-releasing hormone and urocortin in the control of the immune response [J].
Baigent, SM .
PEPTIDES, 2001, 22 (05) :809-820
[7]   mRNA expression profiles for corticotrophin-releasing factor (CRF), urocortin, CRF receptors and CRF-binding protein in peripheral rat tissues [J].
Baigent, SM ;
Lowry, PJ .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2000, 25 (01) :43-52
[8]   Human lymphocytes produce urocortin, but not corticotropin-releasing hormone [J].
Bamberger, CM ;
Wald, M ;
Bamberger, AM ;
Ergün, S ;
Beil, FU ;
Schulte, HM .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (02) :708-711
[9]  
BAYLE JD, 1991, PROG NEUROENDOCRINIM, V4, P99
[10]   Effects of interleukin-2 on the expression of corticotropin-releasing hormone in nerves and lymphoid cells in secondary lymphoid organs from the Fischer 344 rat [J].
Bellinger, DL ;
Felten, DL ;
Lorton, D ;
Brouxhon, S .
JOURNAL OF NEUROIMMUNOLOGY, 2001, 119 (01) :37-50